No exit: targeting the budding process to inhibit filovirus replication

Ronald N Harty1

  • 1Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA 19104, USA. rharty@vet.upenn.edu

Antiviral Research
|December 31, 2008
PubMed

Insights

Ebola and Marburg viruses cause deadly hemorrhagic fevers. Targeting the VP40 matrix protein, crucial for viral budding, offers a promising strategy for developing new filovirus antiviral drugs.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Filoviruses, including Ebola and Marburg, are significant public health threats causing severe hemorrhagic fevers.
  • Despite detailed understanding of filovirus replication, no direct antiviral therapies exist.
  • The VP40 matrix protein is essential for filovirus budding and virion release.

Purpose of the Study:

  • To review current knowledge on the structural and functional domains of the filovirus VP40 matrix protein.
  • To identify key regions of VP40 critical for efficient virion and virus-like particle budding.
  • To highlight VP40 as a potential target for novel antiviral drug development.

Main Methods:

  • Literature review of existing research on filovirus VP40 structure and function.
  • Analysis of studies detailing VP40's role in virus-host interactions and virion egress.
  • Synthesis of information on structural domains essential for budding efficiency.

Main Results:

  • Identified key structural and functional domains within the VP40 matrix protein.
  • Highlighted VP40's critical role in mediating virus-host interactions for efficient virion release.
  • Emphasized the importance of VP40 in the budding process of filoviruses.

Conclusions:

  • Understanding VP40's structure-function relationships is crucial for filovirus control.
  • VP40 represents a rational and novel target for developing inhibitors of filovirus egress.
  • Targeting VP40 could lead to the development of urgently needed antiviral therapies against filoviruses.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...